SCHEMBL13665121

SCHEMBL13665121

Cc1cccc(C#N)c1OCC(=O)OC(C)(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SSTR4 P31391 1/20 0.47
▸ NAMPT P43490 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ ALDH1A1 P00352 5/20 0.40
▸ TSHR P16473 3/20 0.40
▸ HPGD P15428 3/20 0.40
▸ ATM Q13315 1/20 0.40
▸ KMT2A Q03164 3/20 0.38
▸ KDM4E B2RXH2 3/20 0.38
▸ HSD17B10 Q99714 3/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ GLA P06280 1/20 0.38
▸ DDB1 Q16531 1/20 0.38
▸ CRBN Q96SW2 1/20 0.38
▸ NLRP3 Q96P20 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13665119 0.84 ALDH1A1 (0.47) NAMPTL3MBTL1ALDH1A1TSHRHPGD
SCHEMBL10430052 0.83 NLRP3 (0.53) SSTR4NAMPTL3MBTL1ALDH1A1ATM
SCHEMBL13665129 0.81 FFAR1 (0.50) SSTR4NAMPTALDH1A1TSHRHPGD
SCHEMBL2776017 0.79 ALDH1A1 (0.63) L3MBTL1ALDH1A1TSHRHPGDKDM4E
SCHEMBL27373585 0.79 L3MBTL1 (0.44) L3MBTL1ALDH1A1TSHRHPGDATM
SCHEMBL20398155 0.73 DDB1 (0.49) L3MBTL1ALDH1A1TSHRHPGDKMT2A
SCHEMBL13515793 0.73 ALDH1A1 (0.46) ALDH1A1TSHRHPGDKMT2AKDM4E
SCHEMBL13665112 0.73 HSD17B10 (0.51) ALDH1A1TSHRHPGDKMT2AKDM4E
SCHEMBL3193143 0.73 KMT2A (0.41) L3MBTL1ALDH1A1TSHRHPGDATM
SCHEMBL16952724 0.73 TSHR (0.50) SSTR4L3MBTL1ALDH1A1TSHRNLRP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7605158-B2 Carbamoyl-type benzofuran derivatives MITSUBISHI TANABE PHARMA CORPORATION (JP) 2009-10-20 — — US disclosed
US-7605158-B2 Carbamoyl-type benzofuran derivatives MITSUBISHI TANABE PHARMA CORPORATION (JP) 2009-10-20 — — US disclosed
US-20090209511-A1 Benzofuran Derivatives KAWAGUCHI TAKAYUKI 2009-08-20 — — US disclosed
US-20090209511-A1 Benzofuran Derivatives KAWAGUCHI TAKAYUKI 2009-08-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090209511-A1 Benzofuran Derivatives F12, F2, F3 SSTR4 3201/4885NAMPT 2417/4885L3MBTL1 4101/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback